Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
CANCvsHRTSETF Comparison
Tema Oncology ETF (CANC) and Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Health Care. Both CANC and HRTS have the same Total Expense Ratio (TER) of 0.99%. CANC is up 4.1% year-to-date (YTD) with +$41M in YTD flows. HRTS performs worse with -4.19% YTD performance, and -$713K in YTD flows. Run a side-by-side ETF comparison of CANC and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs HRTS performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC HRTS | -0.94%-4.65% | +4.18%-3.57% | +4.10%-4.19% | +43.76%+15.64% | n/an/a | n/an/a |
| Flows | CANC HRTS | +$12M-$2M | +$49M+$712K | +$41M-$713K | +$63M-$17M | -- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC HRTS | +23.29%+14.57% | +25.13%+17.68% | n/an/a | n/an/a |
| Max drawdown | CANC HRTS | -4.68%-7.42% | -17.26%-13.50% | n/an/a | n/an/a |
| Max drawdown duration | CANC HRTS | 16d64d | 80d163d | n/an/a | n/an/a |
CANC | HRTS | |
Last sale 3/13/2026 at 1:30 PM | $36.15 | $33.61 |
| Previous close 03/12/2026 | $36.33 | $33.80 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
CANC | HRTS | |
|---|---|---|
| Last price | $36.15 | $33.61 |
| 1D performance | -0.50% | -0.56% |
| AuM | $161.18 M | $51.79 M |
| E/R | 0.99% | 0.99% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the CANC and HRTS ETFs performed in 2026?
As of March 12, 2026, CANC is up 4.1% year-to-date (YTD), while HRTS has lost -4.19%. That puts CANC better performer ahead so far this year.
Which ETF is attracting more investor money: CANC or HRTS?
Year-to-date, the CANC ETF saw +$41M in flows, compared to -$713K for HRTS.
Which ETF is more volatile: CANC or HRTS?
Over the past year, CANC had a volatility of 25.13%, while HRTS experienced 17.68%.
Which ETF is bigger: CANC or HRTS?
As of March 12, 2026, CANC holds $161.18 M in assets under management (AUM), while HRTS manages $51.79 M.
What sectors do the CANC and HRTS ETFs invest in?
CANC leans toward sectors like Health Care. Meanwhile, HRTS focuses on Health Care.
What are the top holdings of the CANC ETF and HRTS ETF?
CANC top holdings include REVOLUTION MEDICINES INC, BRIDGEBIO PHARMA and NOVARTIS. HRTS holds in its top three: LILLY, US7711951043 and JOHNSON&JOHNSON.
Which ETF is more diversified: CANC or HRTS?
CANC holds 56 securities with 56.2% of its assets in the top 15. HRTS has 44 securities and a top 15 weight of 61.09%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
